FR2331339A1 - Nouveaux composes heterocycliques et composition pharmaceutique les contenant - Google Patents

Nouveaux composes heterocycliques et composition pharmaceutique les contenant

Info

Publication number
FR2331339A1
FR2331339A1 FR7634034A FR7634034A FR2331339A1 FR 2331339 A1 FR2331339 A1 FR 2331339A1 FR 7634034 A FR7634034 A FR 7634034A FR 7634034 A FR7634034 A FR 7634034A FR 2331339 A1 FR2331339 A1 FR 2331339A1
Authority
FR
France
Prior art keywords
pharmaceutical composition
composition containing
heterocyclic compounds
new heterocyclic
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7634034A
Other languages
English (en)
French (fr)
Other versions
FR2331339B1 (US20020051482A1-20020502-M00012.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mundipharma AG
Original Assignee
Mundipharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mundipharma AG filed Critical Mundipharma AG
Publication of FR2331339A1 publication Critical patent/FR2331339A1/fr
Application granted granted Critical
Publication of FR2331339B1 publication Critical patent/FR2331339B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7634034A 1975-11-11 1976-11-10 Nouveaux composes heterocycliques et composition pharmaceutique les contenant Granted FR2331339A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL48453A IL48453A (en) 1975-11-11 1975-11-11 Substituted 6-oxa-1-azatricyclo-(6.2.2.0 )dodecan-5-ones and 1,4-ethano-5-oxo octa (or decahydro)quinoline,their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
FR2331339A1 true FR2331339A1 (fr) 1977-06-10
FR2331339B1 FR2331339B1 (US20020051482A1-20020502-M00012.png) 1980-04-04

Family

ID=11048546

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7634034A Granted FR2331339A1 (fr) 1975-11-11 1976-11-10 Nouveaux composes heterocycliques et composition pharmaceutique les contenant

Country Status (22)

Country Link
US (1) US4083985A (US20020051482A1-20020502-M00012.png)
JP (2) JPS6045198B2 (US20020051482A1-20020502-M00012.png)
AR (1) AR213184A1 (US20020051482A1-20020502-M00012.png)
AT (1) AT355035B (US20020051482A1-20020502-M00012.png)
AU (1) AU511347B2 (US20020051482A1-20020502-M00012.png)
BE (1) BE848227A (US20020051482A1-20020502-M00012.png)
CA (1) CA1078385A (US20020051482A1-20020502-M00012.png)
CH (2) CH635102A5 (US20020051482A1-20020502-M00012.png)
DE (1) DE2650876A1 (US20020051482A1-20020502-M00012.png)
DK (1) DK507376A (US20020051482A1-20020502-M00012.png)
ES (1) ES453162A1 (US20020051482A1-20020502-M00012.png)
FI (1) FI60013C (US20020051482A1-20020502-M00012.png)
FR (1) FR2331339A1 (US20020051482A1-20020502-M00012.png)
GB (1) GB1571511A (US20020051482A1-20020502-M00012.png)
IL (1) IL48453A (US20020051482A1-20020502-M00012.png)
IN (1) IN145202B (US20020051482A1-20020502-M00012.png)
MX (1) MX4767E (US20020051482A1-20020502-M00012.png)
NL (1) NL7612427A (US20020051482A1-20020502-M00012.png)
NO (1) NO144927C (US20020051482A1-20020502-M00012.png)
NZ (1) NZ182556A (US20020051482A1-20020502-M00012.png)
SE (1) SE435929B (US20020051482A1-20020502-M00012.png)
ZA (1) ZA766663B (US20020051482A1-20020502-M00012.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183938A (en) * 1975-11-11 1980-01-15 The Purdue Frederick Company 1,8-Ethano-5-oxo-octa- and -decahydroquinolines and mydriatic compositions thereof
US4855290A (en) 1985-05-10 1989-08-08 State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research Derivatives of quinuclidine
US4876260A (en) * 1987-10-28 1989-10-24 State Of Israel, Israel Institute Of Biological Research Oxathiolanes
JPH0523864Y2 (US20020051482A1-20020502-M00012.png) * 1989-09-05 1993-06-17
US5852029A (en) * 1990-04-10 1998-12-22 Israel Institute For Biological Research Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
US5407938A (en) * 1990-04-10 1995-04-18 Israel Institute For Biological Research Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines)
JPH0518551U (ja) * 1991-08-28 1993-03-09 亀吉 立花 ぶら下がり健康器
US5280028A (en) * 1992-06-24 1994-01-18 G. D. Searle & Co. Benzimidazole compounds
US5521193A (en) * 1992-06-24 1996-05-28 G. D. Searle & Co. Benzimidazole compounds
US5534521A (en) * 1993-06-23 1996-07-09 G. D. Searle & Co. Benzimidazole compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857837A (en) * 1968-07-02 1974-12-31 Hoffmann La Roche Processes and intermediated for quinine, quinidine, isomers and derivatives thereof

Also Published As

Publication number Publication date
US4083985A (en) 1978-04-11
IL48453A0 (en) 1976-01-30
BE848227A (fr) 1977-03-01
ES453162A1 (es) 1977-11-01
DK507376A (da) 1977-05-12
AT355035B (de) 1980-02-11
CA1078385A (en) 1980-05-27
FR2331339B1 (US20020051482A1-20020502-M00012.png) 1980-04-04
JPS6043348B2 (ja) 1985-09-27
NL7612427A (nl) 1977-05-13
IN145202B (US20020051482A1-20020502-M00012.png) 1978-09-09
IL48453A (en) 1980-06-30
AU511347B2 (en) 1980-08-14
CH640234A5 (de) 1983-12-30
NO763820L (US20020051482A1-20020502-M00012.png) 1977-05-12
SE435929B (sv) 1984-10-29
NO144927B (no) 1981-08-31
JPS60120876A (ja) 1985-06-28
JPS6045198B2 (ja) 1985-10-08
ATA839476A (de) 1979-07-15
SE8003351L (sv) 1980-05-05
DE2650876A1 (de) 1977-05-18
ZA766663B (en) 1977-10-26
JPS5283396A (en) 1977-07-12
NZ182556A (en) 1979-10-25
GB1571511A (en) 1980-07-16
NO144927C (no) 1981-12-09
FI60013C (fi) 1981-11-10
FI763152A (US20020051482A1-20020502-M00012.png) 1977-05-12
FI60013B (fi) 1981-07-31
AR213184A1 (es) 1978-12-29
AU1955276A (en) 1978-05-18
CH635102A5 (de) 1983-03-15
MX4767E (es) 1982-09-08

Similar Documents

Publication Publication Date Title
BE867727A (fr) Nouveaux composes de phtalazine et composition pharmaceutique les contenant
LU81349A1 (fr) Nouveaux aminothiazoles et composition pharmaceutique les contenant
BE873500A (fr) Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant
BE859824A (fr) Nouveaux derives d'hydantoine et composition pharmaceutique les contenant
BE867248A (fr) Nouveaux isomeres dextrogyres de spiro-hydantoines asymetriques et compositions pharmaceutiques les contenant
FR2345450A1 (fr) Quinoxalinones et quinoxalines, leurs procedes de preparation et composition pharmaceutique les contenant
LU78330A1 (fr) Procede de preparation de nouveaux derives d'hydantoine et de composition pharmaceutique les contenant
BE880065A (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
FR2283686A1 (fr) Nouveaux composes heterocycliques et compositions pharmaceutiques les contenant
FR2332705A1 (fr) Nouveaux composes heterocycliques, leur preparation, composition les contenant et leurs applications en agriculture
FR2331339A1 (fr) Nouveaux composes heterocycliques et composition pharmaceutique les contenant
BE871623A (fr) Nouveaux derives du tetrazole et compositions pharmaceutiques les contenant
FR2349585A1 (fr) Nouveau derive de xanthine et composition pharmaceutique le contenant
BE811856A (fr) Nouveaux derives de quinazoline et composition pharmaceutique les contenant
BE885389A (fr) Composes penam acetoxymethyles et composition pharmaceutique les contenant
FR2352790A1 (fr) Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant
BE885709A (fr) Nouveaux composes heterocycliques azotes anti-inflammatoires et immunoregulateurs et composition pharmaceutique les contenant
BE832725A (fr) Nouveaux composes meterocycliques et composition pharmaceutique les contenant
FR2329281A1 (fr) Nouveaux 6,8-dioxamorphinanes n-substitues et composition pharmaceutique les contenant
BE815584A (fr) Nouveaux 3-alkyl-9-aminoalkyl-1,2,3,4-tetra-hydrocarbazoles et composition pharmaceutique les contenant
BE837698A (fr) Nouveaux derives de 4-aminoquinoleine, leur procede de preparation et composition pharmaceutique les contenant
FR2303559A1 (fr) Nouveaux derives d'histidine, leur procede de preparation et composition pharmaceutique les contenant
BE884530A (fr) Nouveaux hexahydro-trans-pyrido-indoles et composition pharmaceutique les contenant
BE832121A (fr) Nouveaux composes anti-arythmiques et compositions pharmaceutiques les contenant
FR2340310A1 (fr) Hydrazinophtalazines substituees, leur preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse